Tristel plc (AIM: TSTL)

Market Cap	186.00M
Revenue (ttm)	41.93M
Net Income (ttm)	6.49M
Shares Out	47.69M
EPS (ttm)	0.14
PE Ratio	28.80
Forward PE	24.67
Dividend	0.14 (3.49%)
Ex-Dividend Date	Nov 28, 2024

Volume	14,013
Open	387.00
Previous Close	390.00
Day's Range	378.40 - 390.00
52-Week Range	346.00 - 510.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 25, 2024

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 233
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2024, Tristel's revenue was 41.93 million, an increase of 16.45% compared to the previous year's 36.01 million. Earnings were 6.49 million, an increase of 45.46%.